NAFDAC Alerts Nigerians on Counterfeit Anti-Malaria Tablets, Suspensions In Market
The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted the Nigerian public about counterfeit Paludex tablets and suspensions currently circulating in the market
NAFDAC in a tweet on its verified X account on Wednesday stated that laboratory tests on the products, conducted by a WHO-prequalified lab in Germany, revealed that both the tablets and suspensions contained no Active Pharmaceutical Ingredient (API).
The Paludex tablets (80mg/480mg) are labelled as manufactured by Impact Pharmaceutical Ltd and marketed by MD Life Sciences Ltd, both based in Enugu State. Similarly, the Paludex suspension for paediatric use (180mg/1080mg) is labelled as manufactured by Impact Pharmaceutical Ltd and Ecomed Pharma Ltd, also marketed by MD Life Sciences Ltd.
